Company Description

Oaktree Acquisition Corp. III Life Sciences does not have significant operations.

The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.

It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.

The company was founded in 1995 and is headquartered in Los Angeles, California.

Oaktree Acquisition Corp. III Life Sciences

Country	United States
Founded	2024
IPO Date	Oct 24, 2024
Industry	Shell Companies
Sector	Financials
CEO	Zaid Pardesi

Contact Details

Address: 333 South Grand Avenue, 28th Floor Los Angeles, California 90071 United States
Phone	213 830 6300
Website	oaktreeacquisitioncorp.com

Stock Details

Ticker Symbol	OACC
Exchange	NASDAQ
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$10.00
CIK Code	2029769
CUSIP Number	G6717R104
ISIN Number	KYG6717R1048
SIC Code	6770

Key Executives

Name	Position
Zaid Pardesi	Chief Executive Officer and Director
George A. Martinez	Chief Financial Officer, Principal Accounting and Principal Financial Officer
Mathew M. Pendo	Chief Operation Officer

Latest SEC Filings

Date	Type	Title
Oct 26, 2026	8-K	Current Report
Oct 16, 2026	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 16, 2026	8-K	Current Report
Oct 15, 2026	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 15, 2026	8-K	Current Report
Oct 2, 2026	DEF 14A	Other definitive proxy statements
Sep 21, 2026	PRE 14A	Other preliminary proxy statements
Aug 14, 2026	SCHEDULE 13G	Filing
Aug 13, 2026	SCHEDULE 13G	Filing
Aug 12, 2026	10-Q	Quarterly Report

View All SEC Filings